Full Text View
Tabular View
No Study Results Posted
Related Studies
Spironolactone Safety in Dialysis Patients
This study is currently recruiting participants.
Study NCT00328809.   Last updated on January 25, 2008.
Information provided by State University of New York - Upstate Medical University
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End Stage Renal Disease
Congestive Heart Failure
Additional conditions recognized in this trial
Heart Failure
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Kidney Failure
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
spironolactone
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
State University of New York - Upstate Medical University


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services